Live Breaking News & Updates on Cutaneous Oncology

Stay updated with breaking news from Cutaneous oncology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Single Injection May Revolutionize Melanoma Treatment

Single Injection May Revolutionize Melanoma Treatment
innovationtoronto.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from innovationtoronto.com Daily Mail and Mail on Sunday newspapers.

Shari-pilon-thomas , Amoda-sarnaik , Moffitt-cancer-center , Moffitt-immunology-program , Moffitt-cutaneous-oncology-program , Rose-bengal , Cutaneous-oncology ,

Correct Dx of Cancer Treatment Skin Effects Evaluated

The survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions. ....

Boston , Massachusetts , United-states , Washington , American , Nicoler-leboeuf , Pp-adam-friedman , George-washington-university , Dana-farber-brigham-cancer-center , Department-of-dermatology-at-brigham , American-academy-of-dermatology , Cutaneous-oncology

Dr Eroglu on Addressing Unmet Needs in Mutant Melanoma

Zeynep Eroglu, MD, discusses a phase 1/2 trial that evaluated ceritinib alone and in combination with trametinib in patients with mutant melanoma. ....

Zeynep-eroglu , Moffitt-cancer-center , Department-of-oncologic-sciences , Department-of-cutaneous-oncology , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college , Moffitt-cancer-center , Melanoma-amp-skin-cancer , Onclive-tv ,

Dr Eroglu on Ceritinib With or Without Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses the efficacy and safety of ceritinib as monotherapy and in combination with trametinib in pretreated advanced melanoma. ....

Zeynep-eroglu , Department-of-cutaneous-oncology , Moffitt-cancer-center , Department-of-oncologic-sciences , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college , Pretreated-advanced-melanoma , Trametinib , Ceritinib ,

Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma

Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma. ....

Zeynep-eroglu , Keiran-smalley , Moffitt-cancer-center , Department-of-oncologic-sciences , Cutaneous-oncology , Oncologic-sciences , South-florida-morsani-college , Melanoma , Ceritinib-and-trametinib- , D , Taacr ,